Mayur Ian Somaiya

Mayur Ian Somaiya

50 year
Finance
Health Technology
Consumer Services

Profile

Mayur Ian Somaiya is currently the Chief Financial Officer at NewAmsterdam Pharma Co. NV.
Previously, he held positions such as Managing Director & Senior Research Analyst at Piper Sandler & Co. (Broker) from 2010 to 2013, Managing Director at Thomas Weisel Partners LLC from 2003 to 2009, Managing Director & Senior Analyst at Nomura Securities International, Inc. from 2013 to 2016, Managing Director & Analyst at BMO Capital Markets Corp.
(Broker) from 2016 to 2018, Analyst at Prudential Securities from 1997 to 1999, Senior Analyst at Morgan Stanley & Co. LLC from 2000 to 2002, and Consultant at Carson Group, Inc. (New York) from 1996 to 1997.
He also served as the Chief Financial Officer at TCR2 Therapeutics, Inc. from 2018 to 2021.
Mr. Somaiya obtained his undergraduate degree from New York University in 1995.
He is currently the Chief Financial & Business Officer at Elucida Oncology, Inc.

Mayur Ian Somaiya active positions

Former positions of Mayur Ian Somaiya

CompaniesPositionEnd
TCR2 THERAPEUTICS INC. Director of Finance/CFO 10/12/2021
Analyst-Equity 01/04/2018
Analyst-Equity 01/01/2016
Analyst-Equity 31/10/2013
Analyst-Equity 15/10/2009
See the detail of Mayur Ian Somaiya's experience

Training of Mayur Ian Somaiya

New York University Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Mayur Ian Somaiya's experience

Connections

100 +

1st degree connections

11

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
FRAZIER LIFESCIENCES ACQUISITION CORPORATION

Health Technology

Private companies9

Finance

Finance

Prudential Securities

Finance

Finance

Finance

Finance

Finance

Health Technology

Health Technology

See company connections
  1. Stock Market
  2. Insiders
  3. Mayur Ian Somaiya